banner

Ngathi

Iprofayile yekhampani

I-Innovita Biological Technology Co., Ltd. (kunye ne-subsidiaries yayo, eyaziwa ngokuba yi-"INNOVITA",) yinkampani ye-biotechnology egxile kuphando, uphuhliso, ukuveliswa kunye nokuthengiswa kwe-in vitro diagnostic iimveliso ze-POCT. Iquka i-Innovita (Tangshan) , Innovita (Beijing) kunye ne-Innovita (Guangzhou).

● Yasekwa ngo-2006

● Misela amaziko e-R&D eBeijing naseGuangzhou, kunye nesiseko semveliso eQian'an, Hebei

about-us (3)
about-us (23)

Iprofayile yekhampani

Yasekwa ngo-2006, i-INNOVITA iye yakha amaqonga amathandathu obugcisa afana ne-antigen & nokulungiswa kwe-antibody, inkcubeko yentsholongwane, igolide ye-colloidal, i-ELISA, i-chromatography ye-fluorescence, i-immunofluorescence, kwaye yenza iNkqubo ye-R & D yeSizwe ye-High-tech kwinkalo yophando lwesizwe lwezifo ezosulelayo kunye ezininzi. ezinye iiprojekthi zempilo yoluntu.Ngaphandle koko, i-INNOVITA inamalungelo awodwa abenzi bokuqanjwa kwelizwe ngaphezulu kweshumi kwaye iseka iziko le-R&D laseBeijing, iziko le-R&D laseGuangzhou, isiseko semveliso ye-Hebei.Ngeeworkshops ezinkulu ezicocekileyo, kunye nokumisela igolide ye-colloidal, i-ELISA, i-fluorescence chromatography, i-PCR, imigca yokuvelisa i-immunofluorescence, i-INNOVITA ifumene i-CE kunye ne-ISO13485 isatifikethi.

Okwangoku, iimveliso ze-INNOVITA ziqulethe iimvavanyo zokuxilongwa kokuphefumla, iimvavanyo zokuchuma, iimvavanyo ze-hepatitis, iimvavanyo ze-TORCH, iimvavanyo zentliziyo, iimvavanyo ze-renal kunye nokunye.Inethiwekhi yokuthengisa igubungele onke amaphondo kunye nemimandla yaseTshayina, kwaye yasasazeka kwi-Asia-mpuma ye-Asia, kuMbindi Mpuma, e-Afrika, eLatin America, kwi-European Union kunye neminye imimandla yaphesheya.I-INNOVITA ibambelela kwifilosofi yoshishino oluphakathi kwabathengi, kwaye ikhonza abathengi ngeemveliso ezichanekileyo nezifanelekileyo.Iimfuno zabathengi kukusukela INNOVITA.

Inkqubo yoPhuhliso

  • Ngo-2006
    ● Kusekwe iziko le-R&D laseBeijing.
  • Ngo-2011
    ● Kusekwe amaziko okuvelisa eTangshan.
  • Ngo-2014
    ● I-ISO 13485 eqinisekisiweyo.
  • Ngo-2018
    ● Utyalo-mali olucwangcisiweyo yiGenesis Capital.
    ● Kuqaliswe intsebenziswano yobuchwephesha bamazwe ngamazwe.
  • Ngo-2019
    ● Utyalo-mali olucwangcisiweyo yiSequoia Capital.
  • Ngo-2020
    ● Uvavanyo lokuqala lweNMPA lwe-COVID-19 lwe-IgM/IgG Combo.
    ● Ukuthunyelwa kumazwe/iingingqi ezingaphezu kwama-70.
    ● Kuwongwa ngeNdlela ePhakamileyo kwiNkongolo yeSizwe yeeNcomo zokuLwa i-COVID-19 Pandemic.
    ● Uvavanyo lwe-COVID-19 lwe-IgM/IgG lufumene uGunyaziso lokuSebenzisa oluNgxamisekileyo (EUA) yi-US FDA.
  • Ngo-2022
    ● Intlanganiso yokuqala yokuqaliswa kwi-SSE STAR Market, kwaye iya kufakwa kuluhlu kwiBhodi ye-China Sci-Tech Innovation kungekudala.
  • Amasebe

    about-us (7)

    EBeijing R&D & Iziko leNtengiso

    Ukusekwa:2006

    Gxininisa:I-R&D, ukuvelisa, ukuthengiswa kwemveliso yokuxilongwa kwe-in-vitro, kubandakanywa amaqonga afana ne-immunodiagnosis, ukuxilongwa kwe-molecular, kunye ne-gene chips.

    Qian'an Manufacturing & Logistic Centre

    Ukusekwa:2011

    Indawo:Ukugubungela indawo yeehektare ezili-150, malunga ne-8,000 ㎡ indawo yokusebenzela, exhotyiswe ngemigca emininzi yemveliso yegolide ye-colloidal, i-ELISA, i-PCR.

    Isiqinisekiso:ISO 13485, CE, FDA, NMPA, njl.

    Guangzhou R&D Centre

    Ukusekwa:2020

    Gxininisa:I-R&D yetekhnoloji ye-IVD

    Amaqonga

    plate

    Uthungelwano lweNtengiso

    Emva kweminyaka yophuhliso, i-Innovita sele inokuthengiswa okupheleleyo kunye nenethiwekhi yenkonzo, kunye neendlela zokuthengisa ezigubungela amaphondo angama-32 kunye nemimandla kwi-China yonke, kwaye ithumele kwiimarike zehlabathi ezifana ne-Southeast Asia, Middle East, Afrika, Latin America, Europe, njl.

    Uvavanyo lwe-Innovita 2019-nCoV Ab luboniswe kwiqonga likaxakeka lesizwe lamayeza kunye nezixhobo zonyango

    Ngomhla wama-28 kuFebruwari, 2020, iNkulumbuso uLi Keqiang yahlola iqonga lesizwe likaxakeka lamayeza kunye nezixhobo zonyango ze-COVID-19.Uvavanyo lwe-Innovita 2019-nCoV Ab luboniswe njengovavanyo lokuqala lwe-antibody lwe-NMPA oluvunyiweyo lwe-IgM/IgG, olwaxelwa kwi-CCTV.

    about-us (26)
    about-us (11)

    Uvavanyo lwe-Innovita 2019-nCoV Ab luqanjwe ngu-Academician Zhong Nanshan

    ● Ngemva kwemini ye-23 kaFebruwari 2020, u-Academician Zhong Nanshan wadiza ngexesha lokubonisana okude e-Guangzhou kunye neqela lezonyango lase-Guangdong elileqa ukuya kunceda uJingzhou ukuba uLawulo lweeMveliso zezoNyango lweSizwe luvume izixhobo ezimbini zovavanyo ezintsha ze-2019-nCoV, enye yazo. uveliswe ngu-Innovita (Tangshan) Biological Technology Co., Ltd.

    ● Ikhithi isebenzisa indlela yegolide ye-colloidal, ekwaziyo ukubona i-antibody ye-lgM kumzimba wesigulana.I-antibody ye-lgM inokubonwa ngomhla we-7 wosulelo lwesigulane okanye ngosuku lwe-3 luqala, oluluncedo kakhulu ekuxilongweni kwesigulane.UZhong Nanshan uthe: "Izigulana zinokuchongwa ngokukhawuleza ukuba zixilongwe kakuhle. Oku kunokusinceda ukuba sahlukanise ngokukhawuleza abantu abaqhelekileyo kubantu abosulelekileyo."

    about-us (15)

    Advanced Collective Award

    about-us (8)

    Ukulwa ubhubhane

    Combating Pandemic